AVROBIO INC stock forecast: down to 1.03 USD AVRO stock price prognosis

STOCK

Forecast for Fri 24 May 2024 price 1.03

AVROBIO INC stock price forecast for further price development down to -15.24% (time horizon: 1 day) and price target of 1.03 USD. Short-term (time horizon: 2 weeks) AVROBIO INC share price prediction for 2024-05-24 with daily closed price projections

Key Facts

Symbol AVRO 

ISIN US05455M1009 

CUSIP 05455M100


Currency USD


Category Biological Products (No Diagnostic Substances)

Forecast price change %

Relative Strength Index (RSI)

Finance numbers

Earnings per share -3.31


On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

Summerized Form 10-K with GPT-2

The status of our initial lentiviral-based gene therapy programs is reflected below. 8226; Restoration of protein function. We also are in the process of establishing a CMO partnership in Europe. This concept is illustrated in the graphs below. &# The remainder of the AEs were Grade 2 or Grade 1. 11 As of March 1, 2021, five patients have been dosed in the FAB-GT clinical trial. Bruising, risk of bleeding and fatigue are common due to the thrombocytopenia and anemia. The baseline measurement was taken one month prior to discontinuation of ERT. Intellectual property licensed to us under this agreement relates to our Fabry program. We may terminate the agreement for any reason upon notice to BioMarin. The market for treatment of lysosomal disorders is especially large and competitive. After a BLA is approved, the product also may be subject to official lot release. This amendment to the PHS Act attempts to minimize 34 duplicative testing. 41 Item 1A. Risk Factors Investing in our common stock involves a high degree of risk. As of December 31, 2020, we had cash and cash equivalents of $259.7 million. As of March 1, 2021, we have dosed only 14 patients across four ongoing clinical trials. A failure of one or more clinical studies can occur at any stage of testing. Designation as a breakthrough therapy is within the discretion of the FDA. There is no assurance we will not experience lot failures in the future. There are, in general, relatively few alternative sources of supply for these components. We are in the preliminary stages of building our commercial organization. A primary trend in the U.S. healthcare industry and elsewhere is cost containment. Additionally, HHS, has already implemented certain measures. We cannot predict the initiatives that may be adopted in the future. We can face serious consequences for violations. Our operations also produce hazardous waste products. We may have experienced ownership changes in the past. Any such dispute could have a material adverse effect on our business. Many of our product candidates are in-licensed from third parties. We may not be able to protect our intellectual property rights throughout the world. A patent may only be extended once and only based on a single approved product. An active trading market for our common stock may not be sustained.

Summerized Form 10-K with GPT-2 https://www.sec.gov/Archives/edgar/data/1681087/000156459021014190/0001564590-21-014190.txt
Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

  • Meta analyst score 34.72/100
    • Good financial position.
    • Historical view, profit is not growing.
    • Company revenue is not growing faster compared with the industry.

Institutional ownership list is based on filling form information

Holding name Date Amount
A - BARCLAYS PLC 2023-06-30 22179
NATIXIS 2022-12-31 880000
MetLife Investment Management, LLC 2021-09-30 14655
MetLife Investment Management, LLC 2021-06-30 1502
MetLife Investment Management, LLC 2021-03-31 13849

Fund ownership list is based on filling form information

Fund name Date Amount Profile
Fidelity Concord Street Trust 2023-11-30 42141 Long
Fidelity Concord Street Trust 2023-11-30 47959 Long
Fidelity Concord Street Trust 2023-11-30 27974 Long
Fidelity Concord Street Trust 2023-11-30 188688 Long
Victory Portfolios III 2023-10-31 4257 Long


Bollinger Bollinger Bands for AVROBIO INC can provide the information where the market is moving based on price information.


AVROBIO INC Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.



Converting prices to returns AVROBIO INC.


On-Balance Volume information for AVROBIO INC. On-Balance Volume information can be an indicator for bullish or bearish outcome.



Accumulation / Distribution (A/D) indicator information for AVROBIO INC. The indicator identify divergences between price and volume flow.


Aroon Oscillator information for AVROBIO INC. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.


Average Directional Index (ADX) information for AVROBIO INC. The index can be used to identify the strengh of a trend.


Moving Average Convergence Divergence (MACD) for AVROBIO INC. The indicator helps to predict trend direction and the momentum of the trend.


Stochastic Oscillator as momentum indicator for AVROBIO INC. The indicator is useful for identifying overbought and oversold levels.


Relative Strength Index (RSI) for AVROBIO INC. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].


Heikin Ashi trading signals are generated based on the Heikin Ashi candles, which are a type of candlestick that smooths out the price action and can help to identify trends. Heikin Ashi signals can be used to identify both long and short trading opportunities.


The awesome oscillator is a momentum indicator that measures the speed and strength of price movements. It is calculated by subtracting a 34-period simple moving average (SMA) from a 5-period SMA.


The Parabolic SAR indicator is a trend-following indicator that uses a series of dots to indicate when a trend is likely to reverse. The Parabolic SAR is a lagging indicator, meaning that it does not predict reversals, but rather confirms them after they have already occurred.


Moving Average Crossover


52W High 52W Low Market Cap

Similar shares


AVROBIO INC on Nasdaq

AVROBIO INC on finviz

Figure below show the stock predictions.
Date Closing price Prediction was updated
2024-05-24 1.03 2024-03-29 08:37
2024-05-22 1.04 2024-03-29 08:37
2024-05-23 1.04 2024-03-29 08:37
2024-05-20 1.06 2024-03-29 08:37
2024-05-21 1.05 2024-03-29 08:37
2024-04-19 1.16 2024-03-29 08:37
2024-04-05 1.24 2024-03-29 08:37
2024-05-14 1.08 2024-03-29 08:37
2024-04-24 1.15 2024-03-29 08:37
2024-04-08 1.24 2024-03-29 08:37
2024-04-09 1.22 2024-03-29 08:37
2024-04-15 1.19 2024-03-29 08:37
2024-05-13 1.08 2024-03-29 08:37
2024-05-15 1.07 2024-03-29 08:37
2024-04-01 1.27 2024-03-29 08:37
2024-04-02 1.27 2024-03-29 08:37
2024-04-03 1.26 2024-03-29 08:37
2024-04-10 1.21 2024-03-29 08:37
2024-04-16 1.18 2024-03-29 08:37
2024-04-22 1.16 2024-03-29 08:37
2024-04-23 1.15 2024-03-29 08:37
2024-05-02 1.12 2024-03-29 08:37
2024-05-06 1.11 2024-03-29 08:37
2024-05-07 1.11 2024-03-29 08:37
2024-05-10 1.09 2024-03-29 08:37
2024-05-16 1.07 2024-03-29 08:37
2024-04-25 1.14 2024-03-29 08:37
2024-04-26 1.14 2024-03-29 08:37
2024-05-09 1.10 2024-03-29 08:37
2024-04-04 1.25 2024-03-29 08:37
2024-04-18 1.17 2024-03-29 08:37
2024-05-03 1.12 2024-03-29 08:37
2024-05-17 1.06 2024-03-29 08:37
2024-04-11 1.20 2024-03-29 08:37
2024-04-12 1.20 2024-03-29 08:37
2024-04-17 1.18 2024-03-29 08:37
2024-04-29 1.13 2024-03-29 08:37
2024-04-30 1.13 2024-03-29 08:37
2024-05-08 1.10 2024-03-29 08:37
2024-05-01 1.13 2024-03-29 08:37

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.